Ng T T, Strang J I, Wilkins E G
Monsall unit, Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, United Kingdom.
Clin Diagn Lab Immunol. 1994 Sep;1(5):552-5. doi: 10.1128/cdli.1.5.552-555.1994.
Tuberculous pericarditis is one of the commonest causes of cardiac failure in Transkei and the surrounding regions in southeast Africa. About 20% of patients with clinically diagnosed tuberculous pericardial effusion go on to develop pericardial fibrosis (i.e., construction), a complication which is associated with significant mortality and morbidity. The pathological mechanisms underlying this aberrant inflammatory response are poorly understood, and there is a lack of reliable pointers (clinical or laboratory) in predicting the likelihood of development of constriction. We studied the humoral response to mycobacterial heat shock proteins (65 and 71 kDa) in 25 patients with culture-positive tuberculous pericardial effusion and found a significant correlation between high anti-mycobacterial hsp60 antibody titers (before treatment) and subsequent development of fibrosis (P = 0.035 by logistic regression), which is independent of the effect of the use of prednisolone as adjuvant therapy. Possible mechanisms underlying the pathogenesis of pericardial constriction in tuberculosis are postulated.
结核性心包炎是南非特兰斯凯及非洲东南部周边地区心力衰竭最常见的病因之一。临床上诊断为结核性心包积液的患者中,约20%会发展为心包纤维化(即缩窄),这一并发症与显著的死亡率和发病率相关。这种异常炎症反应的病理机制尚不清楚,且缺乏可靠的(临床或实验室)指标来预测缩窄发生的可能性。我们研究了25例培养阳性的结核性心包积液患者对分枝杆菌热休克蛋白(65 kDa和71 kDa)的体液反应,发现高抗分枝杆菌hsp60抗体滴度(治疗前)与随后的纤维化发展之间存在显著相关性(逻辑回归分析P = 0.035),这与使用泼尼松龙作为辅助治疗的效果无关。文中推测了结核病心包缩窄发病机制的可能原因。